PCRX fundamentals
An in-depth look to PHARMACORP RX INC operating, investing, and financing activities
PCRX free cash flow for Q3 24 is -642.9 k CAD. For 2023, PCRX free cash flow was -519.46 k CAD and operating cash flow was -519.46 k CAD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM